| Filed On | Filing |
|---|---|
| 31 Mar 2022 |
Form 4/A: Beckman Daniella, Director
Received 3,400 shares as a grant or award · Granted 7,000 Stock Option (Right to Buy) |
| 17 Mar 2021 |
Form 4/A: Hurley Ariel, Principal Accounting Officer
Sold 512 shares ($50.4K) |
| 24 Nov 2017 |
Form 4/A: Dorsch Marion, Chief Scientific Officer
Sold 500 shares ($32.2K) |
| 30 Jun 2017 |
Form 4/A: Haviland Kate, Chief Business Officer
Received 12,714 shares by exercise or conversion ($207K) · Sold 12,714 shares ($509K) |
Loading...